GlobeNewswire by notified

Tryg Forsikring A/S prices Perpetual Restricted Tier 1 Capital Notes



In accordance with the company announcement dated 6 March 2023, the offering of the new Perpetual Restricted Tier 1 Capital Notes was priced and subscribed today with significant investor interest. Tryg Forsikring A/S has accordingly decided to issue notes for a nominal amount of SEK 900m and NOK 600m (the "Transaction" of the “Notes”). The Transaction had excess investor demand of more than 1bn and has been placed primarily with Asset Managers and Funds in all the Nordic countries.

The Notes will be issued on 20 March 2023. The NOK Notes will have a variable interest rate of 3M NIBOR +3.45% per annum and the SEK Notes will have a variable interest rate of 3M STIBOR + 3.50% per annum. The first interest payment date on the Notes will be 20 June 2023.

The Notes are perpetual and have no fixed date for redemption, however, Tryg Forsikring A/S has the option, subject to certain Redemption and Purchase Conditions to redeem all of the SEK Notes and/or the NOK Notes at par on any day between 20 March and 20 June 2028, and thereafter, on every Interest Payment Date.

The Notes are expected to be listed on Nasdaq Copenhagen regulated market within 6 months from the Issue Date.

In connection with the Transaction, Tryg Forsikring A/S will purchase SEK 414m of its outstanding SEK 700,000,000 Floating Rate Perpetual Restricted Tier 1 Capital Notes with ISIN DK0030418249 at a price of 101%. The purchase is conditional upon certain conditions, including the settlement of the Transaction.

Additional information:
For further information, visit or contact:

Gianandrea Roberti, Investor Relations Officer +45 20 18 82 67
Peter Brondt, Investor Relations Manager +45 22 75 89 04

This announcement is for information purposes only and is not intended to, and does not, constitute or
form part of any offer, invitation or solicitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or otherwise in any jurisdiction in which such offer, invitation or solicitation is unlawful.
This announcement does not constitute a prospectus, prospectus equivalent document or an exempted document.

About Tryg
Tryg is one of the largest insurance companies in the Nordic region with activities in Denmark, Norway and Sweden. Tryg provides peace of mind and value for more than 5.3 million customers on a daily basis. Tryg A/S is listed on NASDAQ Copenhagen and approximately 45% of the shares are held by TryghedsGruppen smba. TryghedsGruppen, annually, contributes around DKK 650m to peace of mind purposes via TrygFonden.

Notice to U.S. investors
This announcement is not for publication or distribution, directly or indirectly, in or into the United
States of America. This announcement does not constitute an offer to sell, or a solicitation of offers to purchase or subscribe for, securities in the United States. The securities referred to herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended, and may not be offered, exercised or sold in the United States absent registration or an applicable exemption from registration requirements. No public offering of securities is being made in the United States.

Cautionary note about forward-looking statements
This announcement (including any information incorporated by reference in this announcement), oral statements made regarding the potential issuance of Notes and purchase of Existing Notes, and other information published by Tryg Forsikring A/S contain statements which are, or may be deemed to be, "forward-looking statements". Forward-looking statements are prospective in nature and are not based on historical facts, but rather on current expectations and projections of the management of Tryg Forsikring A/S about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. Forward-looking statements often use words such as "believe", "expect", "estimate", "intend", "anticipate" and words of a similar meaning, and phrases or statements that certain actions, events or results "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved (or, in each case, their negative or other variations). You should not place undue reliance on these forward-looking statements, which reflect the current views of Tryg Forsikring A/S, are subject to risks and uncertainties about Tryg Forsikring A/S and are dependent on many factors, some of which are outside of Tryg Forsikring A/S' control. There are important factors, risks and uncertainties that could cause actual outcomes and results to be materially different. Except as required by law, Tryg Forsikring A/S undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Oxurion Publishes 2022 Annual Report31.3.2023 20:42:16 CEST | Press release

Regulated Information Leuven, BELGIUM,Boston, MA, US–March 31, 2023– 07.00 PM CET – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, published its annual report for the financial year 2022. The annual report for the year ending December 31, 2022 is available in the “Investors” section of the Company’s website, and can also be downloaded as a PDF. About Oxurion Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people, as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders, including the successful development of THR-149, its novel therapeut

Nokia Corporation: Repurchase of own shares on 31.03.202331.3.2023 20:00:00 CEST | Press release

Nokia Corporation Stock Exchange Release 31 March 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 31.03.2023 Espoo, Finland – On 31 March 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL221,1864.49CEUX21,0654.50AQEU12,3894.49TQEX7,3604.50Total262,0004.49 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023 a

Fly Play hf.: Amendments to share option plan31.3.2023 20:00:00 CEST | Press release

Amendments to share option plan As detailed in the Company Description in relation to the listing of shares in Fly Play hf. on Nasdaq First North Iceland, dated June 2021, the Company had, in accordance with the remuneration then in force, implemented a share-based incentive program in the form of option rights whereby the Company granted several members of the management team and other key employees options to purchase shares in the Company as part of their remuneration. Having regard for the purposes of the share-based incentive program referred to above, the Board of Directors has decided to extend the exercise period in relation to share options to purchase a total of 16.666.669 shares in the Company, at a purchase price of ISK 8 per share. For a period of 12 months, these options are therefore exercisable until April 2024, at which point the options expire. The options may be exercised at any time during the exercise period.

SBM Offshore completes US$1.63 billion financing of Almirante Tamandaré31.3.2023 19:25:15 CEST | Press release

March 31, 2023 SBM Offshore is pleased to announce it has signed the project financing of FPSO Almirante Tamandaré for a total of US$1.63 billion. The project financing is provided by a consortium of 13 international banks with insurance cover from 4 international Export Credit Agencies (ECA). The financing is composed of five separate facilities with a ca. 6.3% weighted average cost of debt and a 14-year post-completion maturity for both the ECA covered facilities and the uncovered facility. The FPSO’s design incorporates SBM Offshore’s industry leading Fast4Ward® new build, multi-purpose hull. It will be the largest oil producing unit in Brazil with a processing capacity of 225,000 barrels of oil and 12 million m3 of gas per day. The FPSO will have an estimated greenhouse gas (GHG) emission intensity below 10 kgCO2e/boe1 and will benefit from emission reduction technologies such as the closed flare technology which increases gas utilization, preventing it from being burnt into the at